Literature DB >> 7983843

Tarsal joint contracture in dogs with golden retriever muscular dystrophy.

J N Kornegay1, N J Sharp, R O Schueler, C W Betts.   

Abstract

Golden retriever muscular dystrophy (GRMD) is an X-linked myopathy homologous with Duchenne muscular dystrophy of human beings. Affected dogs have progressive clinical dysfunction due to muscle wasting and contractures. Deficits progress particularly rapidly between 3 and 6 months of age. To better characterize the role of contractures in this deterioration, the flexor surface, nonweight-bearing tarsal joint angle was measured in GRMD-affected dogs and clinically normal littermates at both ages. The mean +/- SD tarsal joint angle for clinically normal dogs decreased from 164.6 +/- 6.09 degrees to 145.6 +/- 8.80 degrees between 3 and 6 months (P < 0.0005). The value for GRMD-affected dogs decreased from 153.3 +/- 11.44 degrees to 117.6 +/- 24.55 degrees (P < 0.005). The angle for clinically normal dogs was greater than that for GRMD-affected dogs at both ages (P < 0.05 at 3 months and P < 0.01 at 6 months). The decrease in tarsal joint angle, at times to less than 90 degrees, correlated well with other phenotypic features of GRMD, such as loss of the ability to walk.

Entities:  

Mesh:

Year:  1994        PMID: 7983843

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  14 in total

Review 1.  Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies.

Authors:  C A Collins; J E Morgan
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

Review 2.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

Review 3.  The paradox of muscle hypertrophy in muscular dystrophy.

Authors:  Joe N Kornegay; Martin K Childers; Daniel J Bogan; Janet R Bogan; Peter Nghiem; Jiahui Wang; Zheng Fan; James F Howard; Scott J Schatzberg; Jennifer L Dow; Robert W Grange; Martin A Styner; Eric P Hoffman; Kathryn R Wagner
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-02       Impact factor: 1.784

4.  Plantarflexion contracture in the mdx mouse.

Authors:  Michael W Garlich; Kristen A Baltgalvis; Jarrod A Call; Lisa L Dorsey; Dawn A Lowe
Journal:  Am J Phys Med Rehabil       Date:  2010-12       Impact factor: 2.159

5.  Kinematics of gait in golden retriever muscular dystrophy.

Authors:  Anthony P Marsh; Joel D Eggebeen; Joe N Kornegay; Chad D Markert; Martin K Childers
Journal:  Neuromuscul Disord       Date:  2009-11-22       Impact factor: 4.296

6.  Muscle pathology, limb strength, walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linked myotubular myopathy.

Authors:  Melissa A Goddard; David L Mack; Stefan M Czerniecki; Valerie E Kelly; Jessica M Snyder; Robert W Grange; Michael W Lawlor; Barbara K Smith; Alan H Beggs; Martin K Childers
Journal:  Ann Transl Med       Date:  2015-10

7.  Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs.

Authors:  Peter P Nghiem; Eric P Hoffman; Priya Mittal; Kristy J Brown; Scott J Schatzberg; Svetlana Ghimbovschi; Zuyi Wang; Joe N Kornegay
Journal:  Am J Pathol       Date:  2013-11       Impact factor: 4.307

8.  Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model.

Authors:  Candice Brinkmeyer-Langford; Joe N Kornegay
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

9.  Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy.

Authors:  Martin K Childers; Janet R Bogan; Daniel J Bogan; Hansel Greiner; Melanie Holder; Robert W Grange; Joe N Kornegay
Journal:  Front Pharmacol       Date:  2012-01-09       Impact factor: 5.810

10.  A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.

Authors:  Paul T Martin; Bethannie Golden; Jonathan Okerblom; Marybeth Camboni; Kumaran Chandrasekharan; Rui Xu; Ajit Varki; Kevin M Flanigan; Joe N Kornegay
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.